Hosted on MSN3mon
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
VTRS), UK-based Hikma Pharmaceuticals Plc, (OTC:HKMPF) (OTC:HKMPY) and Indian drugmaker Sun Pharmaceutical Industries. These approvals came after Takeda’s exclusivity on the drug ended ...
Business Insider India4y
Granules India gets tentative nod from USFDA for generic Colchicine capsules
filed by Granules Pharmaceuticals Inc for Colchicine capsules in the strength of 0.6 mg, Granules India said in a filing to the BSE. The company's product is a generic version of Hikma ...